Application of routine electronic health record databases for pharmacogenetic research
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of routine electronic health record databases for pharmacogenetic research
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume 275, Issue 6, Pages 590-604
Publisher
Wiley
Online
2014-03-03
DOI
10.1111/joim.12226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
- (2013) D F Carr et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With Clopidogrel
- (2012) Jae-Sik Jang et al. AMERICAN JOURNAL OF CARDIOLOGY
- Impact of theCYP2C8*3polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone
- (2012) Christina L. Aquilante et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project
- (2012) J M Pulley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics
- (2012) P H O'Donnell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Genetic Information Nondiscrimination Act (GINA): Public Policy and Medical Practice in the Age of Personalized Medicine
- (2012) Eric A. Feldman JOURNAL OF GENERAL INTERNAL MEDICINE
- Pharmacogenomics in clinical practice and drug development
- (2012) Andrew R Harper et al. NATURE BIOTECHNOLOGY
- Potential of adaptive clinical trial designs in pharmacogenetic research
- (2012) Frederieke H van der Baan et al. PHARMACOGENOMICS
- RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment
- (2012) A I Lynch et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects
- (2012) S C Sim et al. PHARMACOGENOMICS JOURNAL
- Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: A systematic review and meta-analysis
- (2012) Yusuke Yamaguchi et al. PLATELETS
- Impact of Patient Selection in Various Study Designs
- (2012) Elizabeth P. Berbano et al. SOUTHERN MEDICAL JOURNAL
- Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain
- (2012) José A. G. Agúndez et al. Frontiers in Genetics
- Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI
- (2011) Bas J.M. Peters et al. ATHEROSCLEROSIS
- VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children
- (2011) T. T. Biss et al. BLOOD
- The Phenotype Standardization Project: Improving Pharmacogenetic Studies of Serious Adverse Drug Reactions
- (2011) M Pirmohamed et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Emerging Role of Electronic Medical Records in Pharmacogenomics
- (2011) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
- (2011) Michael V. Holmes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention
- (2011) A. M. HARMSZE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in The Rotterdam Study
- (2011) Laure Elens et al. Pharmacogenetics and Genomics
- Pharmacogenetics in randomized controlled trials: considerations for trial design
- (2011) Frederieke H van der Baan et al. PHARMACOGENOMICS
- Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
- (2011) Q. Ma et al. PHARMACOLOGICAL REVIEWS
- Copy number variants in pharmacogenetic genes
- (2011) Yijing He et al. TRENDS IN MOLECULAR MEDICINE
- CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study
- (2010) A. M. Harmsze et al. EUROPEAN HEART JOURNAL
- Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives
- (2010) Roberta Russo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Methodological and statistical issues in pharmacogenomics
- (2010) Bas J. M. Peters et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
- (2010) Jean-Sébastien Hulot et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Selection Bias and Information Bias in Clinical Research
- (2010) Giovanni Tripepi et al. NEPHRON CLINICAL PRACTICE
- Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis
- (2010) F Sofi et al. PHARMACOGENOMICS JOURNAL
- The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13) on the effectiveness of statins: the GenHAT study
- (2009) Anke-Hilse Maitland-van der Zee et al. Pharmacogenetics and Genomics
- Pharmacogenomics: Role in Medicines Approval and Clinical Use
- (2009) G. Novelli et al. Public Health Genomics
- Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement— A systematic review and meta analysis
- (2009) Limei Yang et al. THROMBOSIS RESEARCH
- Designing Genome-Wide Association Studies: Sample Size, Power, Imputation, and the Choice of Genotyping Chip
- (2009) Chris C. A. Spencer et al. PLoS Genetics
- The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies
- (2008) SU Yasuda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics: From Bench to Byte
- (2008) JJ Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gene–environment interactions for complex traits: definitions, methodological requirements and challenges
- (2008) Astrid Dempfle et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Electronic Medical Record-Assisted Design of a Cluster-Randomized Trial to Improve Diabetes Care and Outcomes
- (2008) Thomas E. Love et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives
- (2008) Ö Bozkurt et al. JOURNAL OF HUMAN HYPERTENSION
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment
- (2008) Diane B. M. A. Wieren-de Wijer et al. PHARMACY WORLD & SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now